2+ necessary for muscle contraction. The effects of calmodulin on single cardiac and skeletal muscle SR Ca 2+ -release channels were studied using the planar lipid bilayer-vesicle fusion technique. Calmodulin inhibited Ca 2+ -release channel opening by reducing the mean duration of single-channel open events without having an effect on single-channel conductance. Inhibition by caimodulin was dependent on Ca 2+ concentration and occurred in the absence of ATP. The effects of calmodulin were reversed by mastoparan, a calmodulin-binding peptide. Two other calmodulin antagonists [calmidazolium and /V-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide] modified the gating behavior of the channel in the absence of exogenous calmodulin in a concentration-and Ca 2+ -dependent manner. Our results suggest that calmodulin can modulate excitationcontraction coupling by directly interacting with the SR Ca 2+ -release channel of cardiac and skeletal muscle. (Circulation Research 1989;64:352-359) From the
C alcium release from the sarcoplasmic reticulum (SR) is thought to occur via highconductance calcium channels located in the junctional SR membrane of both skeletal and cardiac muscle.'- 3 Although the exact trigger mechanism for calcium release has yet to be determined, calcium ion efflux from isolated membrane vesicles and single calcium-release channel activity have been shown to be regulated by the cellular components Ca 2+ , Mg 2 *, and ATP.'- 4 The ubiquitous calcium-binding protein, calmodulin, has also been implicated as a regulator of calcium release. In two studies, the role of calmodulin was assumed to be that of an activator of protein phosphorylation. 5 -6 Calmodulin-dependent phosphorylation of junctional SR proteins was envisioned as a mechanism for deactivating the skeletal calcium-release channel. 6 In other studies, calmodulin was shown to cause an inhibition of calcium release from isolated cardiac and skeletal SR vesicles in the absence of hydrolyzable nucleotide substrates. 78 This sug-gested that calmodulin was interacting directly with calcium-release channels and not through the regulation of protein phosphorylation.
In this study, it is shown that calmodulin inhibits calcium release by reducing channel open time without having an effect on single-channel conductance. In addition, the single-channel experiments provide evidence in support of the hypothesis that calmodulin acts as a modulator of calcium release through a direct interaction with the cardiac and skeletal Ca 2+ -release channels.
Materials and Methods

Reagents
Phospholipids were purchased from Avanti Polar Lipids Inc (Birmingham, Alabama). ATP, the ATP analogue AMP-PCP, bovine brain calmodulin, and calmodulin inhibitors were from Sigma Chemical Co (St. Louis, Missouri). All other chemicals were reagent grade.
Preparation of Membranes
Canine cardiac and rabbit skeletal muscle SR membranes were prepared by differential and sucrose-gradient centrifugation as described previously. 9 Briefly, cardiac SR Ca 2+ -release vesicle fractions were recovered from the 28-40% region of sucrose gradients that contained membranes sedimenting at 10,000-100,000g. Heavy rabbit skeletal muscle SR Ca 2+ -release vesicles were recovered from the 36-45% region of sucrose gradients that contained membranes sedimenting at 2,600-35,000g.
Planar Bilayer Measurements
Calcium-release channels from cardiac and skeletal SR were incorporated into Mueller-Rudin planar lipid bilayers and recorded as described previously. 2 Briefly, "heavy" SR vesicles were fused into phosphatidylethanolamine, phosphatidylserine, phosphatidylcholine (5:3:2) planar bilayers formed across a 0.25-mm hole drilled in a polyvinylidene-difluoride cup. The cis chamber, to which vesicles were added, contained 5 mM CaCl 2 , 250 mM cholineCl, 10 mM tris(hydroxymethyl)aminomethane/Af-2-hydroxymethylpiperazine-/V'-2-ethanesulfonic acid (Tris/HEPES), pH 7.4, and the trans chamber contained 5 mM CaCl 2 , 50 mM cholineCl, and 10 mM Tris/HEPES, pH 7.4. Fusion of SR vesicles was monitored as CP-specific increases in membrane conductance. After the first fusion event, the chambers were perfused to remove CV and unfused vesicles. Unless otherwise indicated, chambers were perfused with 0.95 mM Ca 2+ , 1 mM EGTA (1.2 fjM free Ca 2+ ), 125 mM Tris/250 mM HEPES, pH 7.4 cis, and with 53 mM Ca(OH)j/ or Ba(OH) ? /250 mM HEPES, pH 7.4 trans. A relatively high Ca 2+ -EGTA buffer system was used in the cis chamber (the cytoplasmic side of SR, Reference 2) to minimize changes in free Ca 2+ concentration on the addition of calmodulin, a Ca 2+binding protein. Under our bi-ionic conditions where E Tra is nominally minus infinity, Ed^^m is nominally positive infinity, and E Hcpes = 0 mV, calcium-release channels could be identified as upward current deflections of 2-3 pA in amplitude at 0 mV holding potential. Single-channel currents were filtered at 4 kHz and stored on videotape using an audioprocessor. 10 For analysis, signals were filtered at 300 Hz and digitized at 2 kHz. Single-channel analysis and the fitting of data histograms were performed as described previously with software run on an IBM-PCXT computer. 2 Open-channel probabilities and time histograms were determined from data stored in 40s files.
Results
Calmodulin added to the cytoplasmic face of cardiac or skeletal calcium-release channels caused a decrease in recorded channel open time. In Figure  1A , two cardiac calcium channels were partially activated by 1. Figure 1C , the current voltage relationship shows that calmodulin had no effect on the singlechannel conductance or permeability characteristics of the channels recorded in our standard buffer conditions. In Figure 2 , a single cardiac calcium-release channel was initially recorded in the presence of 1.2 yM free Ca 2+ cis. Open probability (p 0 ) was 0.45 in this condition (Figure 2A ). In B, 25 seconds after the addition of 2 /xM calmodulin, the channel closed abruptly and remained in a long-lived, nearly fully inactive state. During this quiescent period (2 minutes recorded time), brief unresolved openings occurred at irregular intervals. Such nearly complete inhibition of channel opening was seen only in recordings from bilayers containing single cardiac channels (n=3). In multiple-channel recordings the inhibition by calmodulin was typically that seen in Figure 1 . In Figure 2C , channel activity was restored by raising the free Ca 2+ concentration to 50 fiM. Within 20 seconds after the addition of Ca 2+ , channel open time increased to a value (p o = 0.95) more typically observed in the absence of calmodulin (see below). This suggested that in this particular recording calmodulin did not appear to inhibit the channel at 50 nM free Ca 2+ . Figure 3 shows that in other channel recordings calmodulin partially reduced channel open time at 50 /iM free Ca 2+ . In trace A, several cardiac channels were recorded in the presence of 1.2 /xM free Ca 2+ cis with 53 mM Ba 2+ trans as the current carrier. The control p 0 in this bilayer was uncharacteristically low (0.01) such that only one current level could be distinguished. Cis Ca 2+ was raised to 50 /xM in trace B,, resulting after 60 seconds in nearly complete activation of the channels in B 2 . At this point it became apparent that there were three channels in the bilayer membrane. This is most easily seen from the current histogram profiles to the right of each recording. In Figure 3C , addition of 2 /iM calmodulin cis caused a decrease in the total open-channel current. With calmodulin present, transitions to the single open level were observed whereas before, channel opening was near optimal. The addition of EGTA to the cis chamber lowered free Ca 2+ to 1.3 /xM and resulted in a marked inhibition of channel opening ( Figure  3D,) . Only one open current level was obvious 60 seconds after the addition of EGTA ( Figure 3D2 ), similar to the control ( Figure 3A) . However, p 0 in this case was only 0.005, as compared to 0.01 in trace A. Perfusion of the cis chamber with Tris/ HEPES buffer, pH 7.4, containing 50 (JM free Ca 2+ , caused a partial reversal of the inhibition, evidenced by the reappearance of additional current levels. FIGURE In Figure 4 , a single cardiac channel was recorded before and after the addition of calmodulin and the high-affinity (A^,=0.3 nM) calmodulin-binding peptide, mastoparan. 1112 In the upper trace, the channel was partially activated by 8 fiM free Ca 2+ cis. Addition of 2 /AM calmodulin to the cis chamber reduced channel open time from 0.71 to 0.19. The lower trace shows that addition of 6 ^.M mastoparan cis reactivated the channel to a value close to the p 0 value observed before the addition of calmodulin. In the absence of exogenously added calmodulin, Ca 2+ -release channel activity was not affected by mastoparan at concentrations of up to 12 ^.M. In other control experiments, mastoparan was without effect on Cl~ channel activity and lipid bilayer conductance or capacitance. Figure 4D shows the cumulative open-and closedtime histograms before (left panel) and after (right panel) the addition of calmodulin. The four histograms were fitted by the sum of two exponentials. In the presence of calmodulin, the short and long open-time constants were decreased threefold and 1.7-fold, respectively. The short and long closedtime constants were increased by a similar factor (twofold to threefold) after the addition of calmodulin. In addition, a few long closed events lasting up to 3-4 seconds were observed ( Figure 4B ). These long-lasting events were excluded from the time analysis due to their infrequent occurrence. Time analysis of the current traces in the presence of mastoparan ( Figure 4C ) yielded open (8.2 and 42 msec) and closed (4 and 13 msec) time constants similar to those calculated before the addition of calmodulin.
Effects of calmodulin and Ca
Calmodulin had no effect on channel opening at free Ca 2+ concentrations lower than 0.1 ^M. In Figure 5 , several channels (n^5) were initially recorded at 1.2 fjM free Ca 2+ cis (not shown). Channel activity was reduced to one current level on the addition of EGTA such that free Ca 2+ was 0.06 piM and was recorded before (upper trace) and after (lower trace) the addition of Figure 2 . A decrease in the effectiveness of calmodulin in the presence of ATP to inhibit the cardiac channel was observed in three out of three experiments.
Calmodulin reduces the Ca 2+ -induced Ca 2+ efflux rates from cardiac 8 as well as skeletal 7 SR Ca 2+release vesicles. In Figure 6 is shown calmodulin inhibition of channel opening of a single skeletal channel. In the presence of 1.2 /iM free Ca 2+ and 4 mM ATP ( Figure 7A , upper trace), openings were grouped into long bursts of activity separated by brief closures. Following the addition of 2 /AM calmodulin, the open probability was lowered by a factor of about 2. The duration of bursts was decreased, and openings occurred in smaller clusters of activity with longer closed times ( Figure 7A , lower trace). Cumulative open and closed histograms were constructed from the single-channel data before and after calmodulin addition and fitted with the sum of two exponentials. Both short and long open-time constants were decreased in the presence of calmodulin, as shown in Figure 7B . Closed-time constants were increased to such an extent in the presence of calmodulin that an additional long-time constant was necessary to fit the data ( Figure 7C ).
In addition to mastoparan (Figure 4) , we tested the effects of other calmodulin inhibitors on Ca 2+release channel activity in the presence or absence of calmodulin in the cis chamber. The two calmodulin antagonists calmidazolium and N-(6-aminohexyl)-5-chloro-1-naphthalene sulfonamide (W7) 13 at concentrations of 1-100 (iM did not reverse calmodulin inhibition of channel opening (not shown). One reason for their ineffectiveness may be that the inhibitors act directly on the Ca 2+ -release channel. The effects of W7 were most clearly visualized for the skeletal channel at low free cis Ca 2+ in the presence of 2 mM ATP (Figure 8 opening for prolonged intervals (up to 5-10 seconds). Those long intervals of silent channel activity were interrupted by brief bursts of channel openings lasting up to 1 second. At 100 jtM, W7 reactivated the channel ( Figure 8D ). The channel flickered continuously, and single bursts of activity were no longer apparent. Although most events were too short in duration to be resolved, the unit conductance did not seem to be affected since a few fully resolved events could be detected. Figure 8E shows that an increase of free cis Ca 2+ to the starting condition reactivated the channel to a value close to the p o value found for the Ca 2+ -and ATP-activated channel in trace A. In other single-or multiplechannel recordings, where Ca 2+ -release channels were partially activated by 2.5 /AM Ca 2+ cis in the absence of ATP, W7 at low concentrations (5-25 also had a slightly inhibitory effect.
Discussion
Evidence of a direct role for calmodulin in the regulation of Ca 2+ release from SR has been demonstrated previously using 45 Ca 2+ flux measurements in isolated skeletal and cardiac SR membranes. 7 -8 Micromolar calmodulin was found to inhibit the 45 Ca 2+ efflux rate from isolated skeletal SR vesicles by a factor of 2-3 and from cardiac SR vesicles by threefold to sixfold. The calmodulin effect did not require ATP, was Ca 2+ dependent, and could be reversed by the addition of troponin inhibitor protein, a calmodulin binding protein. 8 Similar to the 43 Ca 2+ flux measurements, the planar bilayer experiments favor a direct interaction of calmodulin with an inhibitory site on the Ca 2+release channel. In single-channel records it is clear that micromolar calmodulin in the presence of micromolar Ca 2+ but in the absence of ATP is sufficient to cause an inhibition of channel opening. A direct interaction of calmodulin with the Ca 2+ -release channel is supported by recent immunological and biochemical studies with the Ca 2+ -release channel probe [ 3 H]ryanodine. The neutral plant alkaloid, ryanodine, which has a profound effect on the unit conductance and gating behavior of the skeletal and cardiac Ca 2+ -release channels, 14 binds specifically to a large oligomeric complex containing the M r~4 00,000 junctional bridging or feet proteins. 15 -17 The feet proteins, which remain during isolation attached to the junctional membrane of heavy SR vesicles and are identical with the Ca 2+ -release channel proteins, 17 have been found to bind calmodulin. 18 Calmodulin inhibited the cardiac and skeletal Ca 2+ -release channels to a similar extent in the vesicle flux 7 -8 and a majority of the lipid bilayer experiments. Some exceptions were noted however for the cardiac channel. In one single-channel recording the cardiac channel was not inhibited by calmodulin in the presence of 50 fiM free Ca 2+ (Figure 2) . Also, we observed some significant differences in the efficacy of calmodulin inhibition of cardiac channels that were recorded in the presence of 1.2 /xM free Ca 2+ cis. In the absence of ATP, calmodulin nearly completely inhibited the cardiac channel in bilayers containing a single channel (Figure 2) , whereas in the presence of ATP, calmodulin reduced channel opening by 20% only (Figure 6 ).
The present study has provided a more detailed picture of the effects of calmodulin on SR Ca 2+release activity than is possible with the vesicle flux measurements. With calmodulin present, the mean duration of single open events of skeletal ( Figure 7 Calmodulin had no effect on the single-channel conductance or permeability properties of the cardiac channel (Figure I) or skeletal channel (not shown), as measured from slope conductance and reversal potential in the presence and absence of calmodulin. Also, the effect of calmodulin was Ca 2+ -dependent and could be reversed by the addition of mastoparan (Figure 4) or by perfusing the cis chamber to remove the added calmodulin ( Figure  3 ). It is not clear whether the calmodulin-induced inhibition is the result of an open-channel blockade or because of binding at some inhibitory site distinct from the conduction pathway. We are inclined to favor the latter hypothesis because of the observation that optimal inhibition of channel activity is reached at 2-4 /xM calmodulin. 78 In an openchannel blockage, a maximal effect should be measurable as nearly total reduction of unit current level.
The effects of several calmodulin antagonists on Ca 2+ -release channel activity were tested. The inhibitory action of calmodulin was reversed by mastoparan, a high-affinity calmodulin-binding protein (^D=0.3 nM). 1112 In our bilayer study we have failed, however, to retrieve a clear reversible effect with other calmodulin inhibitors such as calmidazolium or W7 after modification of single-channel activity by calmodulin. It has been previously shown that mastoparan binds to a different calmodulin site than phenothiazine-related drugs. 1219 Also, inhibitors such as W7 may directly interact with the Ca 2+ -release channel (Figure 8) . At low concentrations an interaction of W7 with one of the Ca 2+activating sites of the channel might be postulated. Ehrlich et al 20 have already reported a "blocking" effect of W7 and its analogues on the Paramecium calcium channel with appearance of long silent periods and no change of unit channel conductance. A second effect of W7 was to activate the skeletal channel at low Ca 2+ and higher W7 concentrations. Increased calcium release from isolated SR vesicles by W7 and other amphiphilic compounds has also been reported. 21 -22 These observations, as well as our single-channel data, suggest that the stimulatory action of W7 is related to calmodulinindependent action of this amphiphilic drug, although an action via a tightly associated calmodulin molecule cannot be ruled out at present.
Thus, in agreement with the previous 43 Ca 2+ flux measurements, 78 our single-channel recordings demonstrate that exogenous calmodulin causes a direct inhibition of Ca 2+ -release channels. A possible physiological role in excitation-contraction coupling could be that calmodulin, by slowing down the release of SR Ca 2+ , compensates for an increase in the level of myoplasmic Ca 2+ during increased muscle activity. Consequently, the effect of calmodulin may help to prevent muscle tetanization during rapid triggering activity.
